The GLP-1 agonist generics market, led by Semaglutide, witnessed heigh...
Semaglutide generics are rapidly reshaping India’s GLP-1 injecta...
Claire Mazumdar Clemon, the founding CEO of Bicara Therapeutics and th...
Mumbai-based pharma firm Cipla has announced the launch of Ciposcillo&...
Akums Drugs & Pharmaceuticals, a Delhi-based Contract Development ...
CN Water will be upgrading its digital lifecycle platform, C...
Sun Pharmaceutical Industries and US-based Organon & Co. have ente...
We live in an interconnected world, where the impact of the ongoing wa...
Across the five-year span from 2020–21 to 2024–25, India&r...
The Pharmaceutical Academy for Global Excellence (PAGE), an initiative...
Graviti Pharmaceuticals, a Hyderabad-based pharmaceutical company with...
Kashiv BioSciences has entered into a definitive agreement to be acqui...
Raay Neo Pharma, a next-generation pharmaceutical company, has officia...
Varun Mukhi is leading Mumbai-based Zyax Chem’s next phase of gr...
Rubicon Research has announced the acquisition of an 85% equity owners...
MSN Laboratories has announced the launch of SEMABEST, its s...
The 9th edition of ‘India Pharma 2026’, the flagship event...
The 9th edition of India Pharma 2026, the flagship even...